Phathom Pharmaceuticals, Inc.(PHAT)
Biotechnology
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-11-05 | Breedlove Robert Charles Principal Accounting Officer | Sale | -524 | -0.95%54,352.4 | $13.51 | $7,079 | View SEC filing | |
| 2025-09-09 | Breedlove Robert Charles Principal Accounting Officer | Sale | -461 | -0.83%54,876.4 | $12.09 | $5,573 | View SEC filing | |
| 2025-07-18 | Breedlove Robert Charles Principal Accounting Officer | Sale | -1,692 | -3.07%53,500.4 | $8.36 | $14,152 | View SEC filing | |
| 2025-05-23 | Topper James N Director | Purchase | +3,780 | +0.06%5,922,827 | $3.86 | $14,609 | View SEC filing | |
| 2025-05-15 | Topper James N Director | Purchase | +7,420 | +0.13%5,919,047 | $3.30 | $24,462 | View SEC filing | |
| 2025-05-13 | Topper James N Director | Purchase | +48,203 | +0.82%5,911,627 | $3.17 | $152,917 | View SEC filing | |
| 2025-05-08 | Parikh Asit Director | Purchase | +10,000 | +11.70%95,500 | $2.50 | $24,985 | View SEC filing | |
| 2025-04-08 | Henderson Molly CFO and CBO | Sale | -3,678 | -3.85%91,779.27 | $4.55 | $16,740 | View SEC filing | |
| 2025-03-17 | Parikh Asit Director | Purchase | +10,000 | +13.25%85,500 | $4.42 | $44,200 | View SEC filing | |
| 2025-01-23 | Henderson Molly CFO and CBO | Sale | -6,583 | -6.45%95,457.27 | $6.59 | $43,371 | View SEC filing | |
| 2025-01-23 | Nabulsi Azmi Chief Operating Officer | Sale | -7,886 | -0.77%1,022,668.93 | $6.59 | $51,957 | View SEC filing | |
| 2025-01-23 | Curran Terrie President and Chief Executive | Sale | -19,109 | -4.98%364,305.16 | $6.59 | $125,884 | View SEC filing | |
| 2024-12-20 | Nabulsi Azmi Chief Operating Officer | Sale | -1,118 | -0.11%1,028,581.93 | $8.00 | $8,944 | View SEC filing | |
| 2024-12-20 | Henderson Molly CFO and CBO | Sale | -1,291 | -1.27%100,067.27 | $8.00 | $10,328 | View SEC filing | |
| 2024-12-16 | KARBE FRANK Director | Purchase | +12,500 | +28.09%57,000 | $7.93 | $99,084 | View SEC filing | |
| 2024-12-16 | Parikh Asit Director | Purchase | +10,000 | +15.27%75,500 | $8.12 | $81,248 | View SEC filing | |
| 2024-07-17 | Nabulsi Azmi Chief Operating Officer | Sale | -10,901 | -1.05%1,029,699.93 | $11.72 | $127,760 | View SEC filing | |
| 2024-07-17 | Henderson Molly CFO and CBO | Sale | -4,325 | -4.09%101,358.27 | $11.72 | $50,689 | View SEC filing | |
| 2024-07-17 | Curran Terrie President and Chief Executive | Sale | -33,848 | -8.15%381,574.16 | $11.72 | $396,699 | View SEC filing | |
| 2024-04-10 | Henderson Molly CFO and CBO | Sale | -3,435 | -3.41%97,174.27 | $11.10 | $38,129 | View SEC filing | |
| 2024-03-26 | Curran Terrie President and Chief Executive | Sale | -16,851 | -3.91%414,624.16 | $9.11 | $153,513 | View SEC filing | |
| 2024-01-25 | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | Sale | -3,703,703 | -49.65%3,755,583 | $8.10 | $29,999,994 | View SEC filing | |
| 2024-01-22 | Henderson Molly CFO and CBO | Sale | -6,307 | -5.90%100,609.27 | $7.75 | $48,900 | View SEC filing | |
| 2023-11-21 | Henderson Molly CFO and CBO | Sale | -2,127 | -2.00%104,195.27 | $7.24 | $15,403 | View SEC filing | |
| 2023-11-08 | Parikh Asit Director | Purchase | +7,500 | +15.79%55,000 | $7.81 | $58,580 | View SEC filing |
1-25 of 89